Top Stories

Germany’s BioNTech buys British AI startup InstaDeep

Published by Uma Rajagopal

Posted on January 11, 2023

2 min read

· Last updated: February 2, 2026

Add as preferred source on Google
Test tubes with BioNTech logo symbolizing AI advancement in biopharma - Global Banking & Finance Review
Image of test tubes in front of the BioNTech logo, illustrating the company's acquisition of AI startup InstaDeep to enhance biotech research and manufacturing capabilities.
Global Banking & Finance Awards 2026 — Call for Entries

(Reuters) -BioNTech SE has agreed to acquire British artificial intelligence (AI) startup InstaDeep for up to 562 million pounds ($682 million) to speed up its biotech research and manufacturing capabilities. Under the German vaccine maker’s largest takeover deal to date, BioNTech is to pay 362 million pounds upfront, in a mix of cash and an […]

(Reuters) -BioNTech SE has agreed to acquire British artificial intelligence (AI) startup InstaDeep for up to 562 million pounds ($682 million) to speed up its biotech research and manufacturing capabilities.

Under the German vaccine maker’s largest takeover deal to date, BioNTech is to pay 362 million pounds upfront, in a mix of cash and an unspecified number of BioNTech shares, and up to 200 million pounds contingent on InstaDeep’s future performance.

“Our goal with the acquisition is to integrate AI seamlessly in all aspects of our work – from target discovery, lead discovery to manufacturing and delivery of our products,” BioNTech co-founder and Chief Executive Ugur Sahin said at the J.P. Morgan healthcare conference on Tuesday.

Sahin also cited BioNTech’s partnership last week with the U.K. government for development of personalized cancer therapies and how AI would help in that.

The transaction adds to a slew of deals as the industry meets in San Francisco for the conference this week.

With estimated COVID-19 vaccine revenues of up to 17 billion euros ($18.2 billion) in 2022 alone, BioNTech is well funded to advance its work on new cancer immunotherapies and on other vaccines, and AI will play a growing role.

BioNTech was part of a group of investors who participated in a $100 million financing round at InstaDeep a year ago. It declined to say precisely how much it had invested then or what share of InstaDeep it held.

BioNTech said it was already involved in dozens of joint projects with InstaDeep, including efforts unveiled last year to quickly determine whether a new coronavirus variant is a cause for concern.

InstaDeep, with about 240 staff, will continue to provide its AI and machine learning services to other companies, including Google and Nvidia, the statement added.

($1 = 0.9325 euros)

($1 = 0.8244 pounds)

(Reporting by Ludwig Burger, Pratik Jain and Leroy Leo; Editing by Shinjini Ganguli, Shailesh Kuber and Maju Samuel)

Frequently Asked Questions

What is artificial intelligence?
Artificial intelligence (AI) refers to the simulation of human intelligence in machines programmed to think and learn. It enables systems to perform tasks that typically require human intelligence, such as problem-solving and decision-making.
What is a merger and acquisition?
A merger and acquisition (M&A) is a financial transaction where two companies combine (merger) or one company purchases another (acquisition). This process is often aimed at growth, diversification, or gaining competitive advantages.

Tags

Related Articles

More from Top Stories

Explore more articles in the Top Stories category